We are live on ! Find out more
EVGN icon

Evogene

18 hedge funds and large institutions have $52.6M invested in Evogene in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

6% more funds holding

Funds holding: 1718 (+1)

0.08% more ownership

Funds ownership: 2.44%2.51% (+0.08%)

4% less capital invested

Capital invested by funds: $54.6M → $52.6M (-$1.98M)

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
7
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

EVGN Hedge Fund Activity: Q3 2015 in Review

18 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q3 2015, worth a combined $52.6M — down 3.6% from $54.6M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new EVGN positions and 1 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $593K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $663K sold.

  • 18 institutional investors held Evogene (EVGN) as of Q3 2015, up from 17 in Q2 2015.
  • Funds reported $52.6M of Evogene stock for Q3 2015, down 3.6% quarter-over-quarter.
  • 2 funds opened new Evogene positions in Q3 2015 and 1 closed out, a net change of +1 holder.
  • The largest Evogene buyer in Q3 2015 was Goldman Sachs, an estimated $593K added.
  • The largest Evogene seller in Q3 2015 was JP Morgan Chase, an estimated $663K sold.

Based on aggregated 13F filings for Q3 2015.